Danny Bega, MD, of Northwestern Medicine Neurology, joins Will Meador, MD, to discuss a major breakthrough in Huntington’s disease — a gene therapy that has shown the first evidence of slowing disease progression. Dr. Bega talks about how the RESET-HD trial is reshaping treatment possibilities and what physicians should watch for as this therapy advances.
